Notably, we found that the currently targetable gene CD52 was transcriptionally regulated by GATA2 and TAL1 in AML cells (Fig. 4I), and the expression of CD52 was positively correlated with the activity of these regulators in single cells (Supplementary Fig. S6D, E). The gene discussed is GATA2; the disease is acute myeloid leukemia.